when should i take my tirzepatide shot How to inject with a syringe: complete step-by-step guide How to Inject Tirzepatide (Zepbound/Mounjaro):

The SURMOUNT-1 trial showed an average of 22.5% weight loss at 72 weeks at 15mg, with over half of the participants reporting more than 20% loss of their body weight

Chen PH, Chang CK, Shih CM, Cheng CH, Lin CW, Lee CC, et al

Altogether, 281 patients (45 in placebo, 46 in 1.5 mg dulaglutide group, 47 in retatrutide 0.5 mg group, 23 in 4 mg escalation group, 24 in 4 mg group, 26 in 8 mg escalation group, 24 in 8 mg fast escalation group, and 46 in 12 mg escalation group) were included in the final analysis

and AHA Scientific Sessions 2024 Online Program Planner AHA Scientific Statement: Significant gaps between science of obesity and the care patients receive (May 2024) AHA health information: Living with Heart Failure and Managing Advanced HF AHA health information: Heart Failure Tools and Resources For more news at AHA Scientific Sessions 2024, follow us on X @HeartNews,#AHA24 ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives

Some people may experience mild side effects like nausea, vomiting, or abdominal pain, but these usually go away after a few weeks